Expression of vascular endothelial growth factor in human dysfunctional temporomandibular joint discs

Archives of Oral Biology

Volumn 48, Issue 3, 2003, Pages 185-192

  Leonardi, R ^a   Lo Muzio, L ^b   Bernasconi, G ^c   Caltabiano, C ^a   Piacentini, C ^c   Caltabiano, M ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Chondrocyte; Disc; Temporomandibular joint; VEGF; Vessel

Indexed keywords

EID: 0242684661     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9969(02)00207-8     Document Type: Article

References (44)

1. Rees L. The structure and function of the mandibular joint. Br Dental J 1954;96:125-131.
2. Dixon A. Structure and functional significance of the intra-articular disc of the human temporomandibular joint. Oral Surg Oral Med Oral Pathol 1962;15:48-59.
3. Bronstein SL, Merrill RG. Clinical staging for TMJ internal derangement: application to arthroscopy. J Craniomandibular Disorders Facial Oral Pain 1992;6:7-16.
4. Yoshida H, Fujita S, Nishida M, Iizuka T. Angiogenesis in the human temporomandibular joint studied by immunohistochemistry for CD34 antigen. J Oral Pathol Med 1999a;28:289-292.
5. Sholley MM, Ferguson GP, Seibel HR, Montour JL, Wilson JD. Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells. Laboratory Investigation 1984;51:624-634.
6. Jakeman LB, Armanini M, Phillips HS, Ferrara N. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 1993;133:848-859.
7. Senger DR, Van de Water L, Brown LF, Nagy JA, Yeo KT, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 1993;12:303-324.
8. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995a;146:1029-1039.
9. Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 1995b;107:233-235.
10. Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994;180:341-346.
11. Brown LF, Detmar M, Claffey K, Nagy JA, Feng D, Dvorak AM, et al. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS 1997;79:233-269.
12. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, Di Pietro LA. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998;152:1445-1452.
13. Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Hormone Res 2000;55:15-35.
14. Detmar M, Yeo KT, Nagy JA, Van de Water L, Brown LF, Berse B, et al. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Investigative Dermatol 1995;105:44-50.
15. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nature Med 1999;5:623-628.
16. Horner A, Bishop NJ, Bord S, Beeton C, Kelsall AW, Coleman N, et al. Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J Anatomy 1999;194:519-524.
17. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994;152:4149-4156.
18. Nagashima M, Yoshino S, Ishiwata T, Asano G. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 1995;22:1624-1630.
19. Nagashima M, Asano G, Yoshino S. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis. J Rheumatol 2000a;27:2339-2342.
20. Walsh DA, Wade M, Mapp PI, Blake DR. Focally regulated endothelial proliferation and cell death in human synovium. Am J Pathol 1998;152:691-702.
21. Maeno N, Takei S, Imanaka H, Takasaki I, Kitajima I, Maruyama I, et al. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis. J Rheumatol 1999;26:2244-2248.
22. Ikeda M, Hosoda Y, Hirose S, Okada Y, Ikeda E. Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritis. J Pathol 2000;191:426-433.
23. Giatromanolaki A, Sivridis E, Athanassou N, Zois E, Thorpe PE, Brekken RA, et al. The angiogenic pathway vascular endothelial growth factor/flk-1 (KDR)-receptor in rheumatoid arthritis and osteoarthritis. J Pathol 2001;194:101-108.
24. Pufe T, Petersen W, Tillmann B, Mentlein R. The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheumatism 2001;44:1082-1088.
25. Marchetti C, Piacentini C, Farina A, Bernasconi G, Calligaro A. A microcopic and immunocytochemical study of structural changes in dysfunctional human temporomandibular joint discs. Arch Oral Biol 1997;40:549-557.
26. Yoshida H, Fujita S, Nishida M, Iizuka T. Localization of lymph capillaries and blood capillaries in human temporomandibular joint discs. J Oral Rehabilitation 1999b;26:600-607.
27. Leonardi R, Villari L, Piacentini C, Bernasconi G, Baciliero U, Travali S. CD44 standard form (CD44H) expression and distribution in dysfunctional human temporomandibular joint discs. Int J Oral Maxillofacial Surgery 2000a;29:296-300.
28. De Bont LGM, Stegenga B. Pathology of temporomandibular joint internal derangement and osteoarthosis. Int J Oral Maxillofacial Surgery 1993;22:71-74.
29. Leonardi R, Villari L, Bernasconi G, Piacentini C, Baciliero U, Travail S. Cellular S-100 protein immunostaining in human dysfunctional temporomandibular joint discs. Arch Oral Biol 2000b;45:411-418.
30. Yoshida H, Fujita S, Nishida M, Iizuka T. Immunohistochemical distribution of lymph capillaries and blood capillaries in the synovial membrane in cases of internal derangement of the temporomandibular joint. J Oral Pathol Med 1997;26:356-361.
31. Carls FR, von Hochstetter A, Makek M, Engelke W. Diagnostic accuracy of TMJ arthroscopy in correlation to histological findings. J Cranio-Maxillo-Facial Surgery 1995;23:75-80.
32. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Rev 1997;18:4-25.
33. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 1995;270:12607-12613.
34. Carlevaro MF, Cermelli S, Cancedda R, Cancedda F. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 2000;113:59-69.
35. Pepper MS, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991;181:902-906.
36. Moses MA, Sudhalter J, Langer R. Isolation and characterization of an inhibitor of neovascularization from scapular chondrocytes. J Cell Biol 1992;119:475-482.
37. Ben-Av P, Crofford U, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 1995;372:83-87.
38. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996;271:736-741.
39. Jackson JR, Minton JA, Ho ML, Wei N, Winkler JD. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta. J Rheumatol 1997;24:1253-1259.
40. Fujita S, Iizuka T, Yoshida H, Sesami N. Transforming growth factor and tenascin in synovial chondromatosis of the temporomandibular joint. Report of a case. Int J Oral Maxillofacial Surgery 1997;26:258-259.
41. Sandler NA, Buckley MJ, Cillo JE, Braun TW. Correlation of inflammatory cytokines with arthroscopic findings in patients with temporomandibular joint internal derangements. J Oral Maxillofacial Surgery 1998;56:534-543.
42. Emshoff R, Puffer P, Rudisch A, Gassner R. Temporomandibular joint pain: relationship to internal derangement type, osteoarthrosis, and synovial fluid mediator level of tumor necrosis factor-alpha. Oral Surgery Oral Med Oral Pathol Oral Radiol Endodontics 2000;90:442-449.
43. Iizuka M, Yamauchi M, Ando K, Hori N, Furusawa Y, Itsukaichi H, et al. Quantitative RT-PCR assay detecting the transcriptional induction of vascular endothelial growth factor under hypoxia. Biochem Biophys Res Commun 1994;205:1474-1480.
44. Ichigatani M, Saga T, Yamaki K, Yoshizuka M. Appearance of vascular endothelial growth factor (VEGF) in femoral head in the growing rat. Histol Histopathol 2001;16:463-468.